The present invention extends to a design of a needle hub and an actuator of a catheter assembly that allows the needle hub and actuator to interlock within the catheter hub. This interlocking allows the needle hub to be inserted into the catheter hub thereby increasing the rigidity of the catheter assembly. The interlocking can be accomplished by forming channels in the proximal end of the actuator and corresponding protrusions from the distal end of the needle hub. In some embodiments, the channels and protrusions can be formed at the top and bottom of the catheter hub and needle hub respectively to thereby increase the vertical rigidity of the catheter assembly. The increase in vertical rigidity can prevent flexing of the catheter hub with respect to the needle shield when a downward force is applied to the catheter assembly such as is common during insertion of the needle.

A spray canister device includes a canister containing a liquid product, a canister housing having an opening, a chassis element, and a tray slidably coupled to the chassis element. The canister includes an actuator cap and is positioned in the canister housing such that a nozzle of the actuator cap is positioned proximate the opening. The canister housing, and the canister positioned therein, may be engaged with the tray via at least one protruding member. Once engaged, the tray may be slidably moved along the chassis element between a retracted position and an extended position to facilitate relative movement between the canister and the canister housing to compress the actuator cap of the canister and spray the liquid product.

An oscillating positive expiratory pressure apparatus having a housing defining a chamber, a chamber inlet, a chamber outlet, a deformable restrictor member positioned in an exhalation flow path between the chamber inlet and the chamber outlet, and an oscillation member disposed within the chamber. The deformable restrictor member and the oscillation member are moveable between an engaged position, where the oscillation member is in contact with the deformable restrictor member and an disengaged position, where the oscillation member is not in contact with the deformable restrictor member. The deformable restrictor member and the oscillation member move from the engaged position to the disengaged position in response to a first exhalation pressure at the chamber inlet, and move from the disengaged position to an engaged position in response to a second exhalation pressure at the chamber inlet.

The invention relates to a stopper arrangement for a drug delivery device, comprising a stopper, a linear actor coupled with one end to the stopper and with an opposite end to a coupling arrangement, wherein the stopper arrangement is configured to be disposed within a container of a drug delivery device, wherein a shape and/or material of the stopper and the coupling arrangement are configured such that a first frictional force between the coupling arrangement and the container is lower than a frictional force between the stopper and the container when the linear actor is contracting and that second frictional force between the coupling arrangement and the container is greater than the frictional force between the stopper and the container when the linear actor is expanding.

The specification discloses a portable dialysis machine having a detachable controller unit and base unit. The controller unit includes a door having an interior face, a housing with a panel, where the housing and panel define a recessed region configured to receive the interior face of the door, and a manifold receiver fixedly attached to the panel. The base unit has a planar surface for receiving a container of fluid, a scale integrated with the planar surface, a heater in thermal communication with the planar surface, and a sodium sensor in electromagnetic communication with the planar surface. Embodiments of the disclosed portable dialysis system have improved structural and functional features, including improved modularity, ease of use, and safety features.

A pharmaceutical cartridge holding unit holds a pharmaceutical cartridge and is mounted to a pharmaceutical injection device main body in order to mount the pharmaceutical cartridge to a pharmaceutical injection device. The pharmaceutical cartridge holding unit comprises an outer peripheral cap having a distal end opening and a rear end opening, and a cartridge cover that is disposed on the inside of the outer peripheral cap and is held in a state of being able to slide forward and backward with respect to the outer peripheral cap. The outer peripheral cap has a guide component that guides the sliding of the cartridge cover forward and backward, stoppers that prevent the cartridge cover from coming loose from the outer peripheral cap, and protrusions that can engage with the pharmaceutical injection device main body.

A fluid management system for the treatment of ascites, pleural effusion or pericardial effusion is provided including an implantable device including a pump, control circuitry, battery and transceiver; a charging and communication system configured to periodically charge the battery and communicate with the implantable device to retrieve performance data; and monitoring and control software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable device and charging and communication system. The implantable device includes a number of features that provide automated movement of fluid to the bladder with reduced risk of clogging, with no patient involvement other than occasional recharging of the battery of the implantable device. The monitoring and control software is available only to the treating physician, such that the physician interacts with the implantable device via the charging and communication system.

A dry powder inhaler including replaceable cartridges containing a dry powder for local or systemic delivery through the pulmonary tract and lungs is disclosed. The inhalers are used with inhalable dry powders, including medicament formulations comprising active agents for local or systemic delivery and for the treatment of diseases such as, pulmonary hypertension, cardiovascular disease, anaphylaxis, diabetes, obesity, cancer, and other diseases, or symptoms associated with these and other diseases, such as nausea, vomiting, pain and inflammation.

Described herein are devices, systems, and methods for generating a variable liquid vacuum with an accompanying stable gas flow rate. In particular, when a suction device suctions a liquid and gas mixture it is advantageous to provide a variable vacuum or vacuum to apply to the liquid component while the flow rate of the gas stays constant or essentially constant.

Devices, systems, and methods interface a cassette with an eye treatment system console to provide coupling between the console and an eye treatment probe. The console may receive the cassette using a driven axial translation linkage that inhibits rotation of the cassette. The cassette may facilitate accurately positioning of a pressure sensor relative to a the console by allowing sliding movement between the sensor and a cassette body. Multiple peristaltic drives may be mounted to the console so that their rotors rotate about a common axis. An integrated mount structure may support and/or position components of the console which will interface with cassette, and an axially compressible vacuum connector of the console seal to a tapered vacuum coupler of the cassette.